Short-term effects of semaglutide among patients with obesity with and without food addiction: an observational study.

Joana NicolauMaría Isabel TamayoPilar SanchísAntelm PujolGuadalupe Pérez-BecGuido SfondriniLluís Masmiquel

Published in: Journal of addictive diseases (2024)

Semaglutide is an effective tool for the amelioration of FA symptomatology among PwO. Despite PwO with FA had greater basal BMI and fat mass, semaglutide showed similar results compared to PwO without FA in terms of weight and fat mass loss at short term.

Keyphrases

weight gain
weight loss
adipose tissue
body mass index
insulin resistance
metabolic syndrome
fatty acid
type diabetes
physical activity
high fat diet induced
climate change